Search results for Liquid Biopsy

Abstract No. LBA15 Liquid Biopsy Detection of TP53, mGSTP1, and mRASS1Fa from Circulating Tumor DNA Improves the Non-inv...

Alpha fetoprotein (AFP) is used to screen high risk patients for hepatocellular carcinoma (HCC) but has limited sensitivity, demanding the identification of new biomarkers. This st...

New Blood Test Detects Tumor DNA to Guide Treatment in Advanced Cancer Cases

In a groundbreaking advancement presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026), researchers have unveiled a promising approach to tail...

Low-Cost, Single Sample Blood Test Detects Different Cancers, Liver Disorders, and Other Diseases

Researchers developed a blood test that, in early studies in more than 1,000 people, showed promise as a low-cost method for detecting multiple cancers, various liver conditions, a...

70 A MACHINE LEARNING-BASED EXOSOMAL LIQUID BIOPSY ENABLES STRATIFICATION OF OCCULT METASTASIS RISK IN PATIENTS WITH INT...

Blood test powered by AI shows early promise in monitoring rare childhood cancer

A new liquid biopsy test using artificial intelligence models could help spot a rare type of bone and soft tissue cancer that predominantly affects children and adolescents.

RNA sequencing identifies blood-based biomarkers for inflammatory breast cancer

RNA sequencing using TGIRT technology reveals blood-based RNA biomarkers that may improve diagnosis and monitoring of inflammatory breast cancer through liquid biopsy...

New blood test spots four cancers and other diseases by stripping away healthy DNA noise

MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare disease signals stand out more clearly. In more than 1...

AI-powered, next-generation sequencing blood-based assay evaluated for detection of post-HCT relapse in AML and MDS

RNA sequencing and AI-powered blood monitoring may detect relapse earlier after hematopoietic cell transplantation, improving risk prediction in AML and myelodysplastic syndrome pa...

This compact Chinese device can detect cancer biomarkers in a drop of blood

A single drop of blood could soon be used to screen for early-stage cancer, according to Wen Liaoyong of Westlake University in Hangzhou. Wen’s team has compressed what was once a...

Circulating Tumor DNA (ctDNA)

Why Your Doctor Recommends Circulating Tumor DNA (ctDNA)? Everything You Should Know Abstract Tumor cells continuously shed nucleic acid fragments ... Read more The post Circulatin...

Cell-free DNA reveals tumor-linked nucleosomal patterns

In a revolutionary breakthrough poised to redefine cancer diagnostics, researchers have unveiled a cutting-edge technique that meticulously dissects the size of cell-free DNA fragm...

Wobble Genomics to present novel mRNA sequencing research at AACR 2026

RNA sequencing of full-length mRNA from blood supports liquid biopsy approaches for selecting antibody-drug conjugate therapies in breast cancer, improving precision treatment deci...

Simple and Cheap Blood Test Could Detect Cancer and Other Diseases Before Symptoms Appear

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin. UCLA researcher...

Blood-based DNA signals may help track osteosarcoma in children

Detecting whether osteosarcoma, a rare but aggressive bone cancer that most often affects children and adolescents, has returned or spread remains a major challenge for patients an...

Breast cancer’s next precision medicine revolution may lie in molecular residual disease

New data shows potential for ctDNA to guide treatment decisions for patients with triple-negative breast cancer

New AI Blood Test Detects Silent Liver Disease Before Symptoms Appear

An AI-powered blood test that analyzes DNA fragments could detect silent liver disease long before symptoms begin. Scientists at the Johns Hopkins Kimmel Cancer Center have develop...

Biomarker Combinations and Novel Surveillance Strategies: A "Traffic Light" Approach and Resource Optimization

72 MOLECULAR TESTING WITH BILISEQ IMPROVES THE DETECTION OF MALIGNANCY AMONG INDETERMINATE BILIARY STRICTURES: A PROSPEC...

Учёные создали тест для диагностики рака по одной капле крови

Канадские ученые разработали новый метод диагностики рака крови, который может заменить болезненную биопсию костного мозга. Тест позволяет выявлять заболевание по обычному анализу...

Blood-based approach could detect early heart, kidney disease, study finds

Scientists know that damage to microscopic blood vessels can provide an early warning sign of heart and kidney disease. But current methods for monitoring these tiny vessels are to...

Optimizing the Evaluation of Biomarkers for HCC Surveillance

How MRD Testing Is Reshaping Breast Cancer Risk Assessment

New B-59 data shows circulating tumor DNA (ctDNA) and molecular residual disease (MRD) testing can better predict recurrence risk and help guide more personalized care in TNBC.

Cheap Blood Test Might Spot Cancers, Other Diseases

TUESDAY, April 7, 2026 — A simple and cost-effective blood test might be able to help detect multiple cancers and other diseases, a new study says. The test works by analyzing DNA...

RNA sequencing of blood samples can monitor immune responses and help tailor treatment for high-risk patients.

RNA sequencing of blood samples may help predict immune response to chemoimmunotherapy and support more personalized treatment strategies for high-risk...